The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera

Current guidelines recommend therapeutic phlebotomy for all polycythemia vera (PV) patients and additional cytoreductive therapy (eg, hydroxyurea [HU]) for high-risk PV patients. Little is known about the impact of these therapies in the real-world setting. We conducted a retrospective cohort study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Podoltsev, Nikolai A., Zhu, Mengxin, Zeidan, Amer M., Wang, Rong, Wang, Xiaoyi, Davidoff, Amy J., Huntington, Scott F., Giri, Smith, Gore, Steven D., Ma, Xiaomei
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199652/
https://ncbi.nlm.nih.gov/pubmed/30333100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018021436
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados